The underperformance in Pfizer (PFE) may come to an end. The media reported that Starboard Value took an approximately $1 ...

JPMorgan analyst Samik Chatterjee downgraded Mobileye to Underweight from Neutral with a price target of $10, down from $16.

Ultrasound is perhaps best known as the technology that enables noninvasive body scans and underwater communication and can ...

Fintel reports that on October 7, 2024, JP Morgan downgraded their outlook for Mobileye Global (NasdaqGS:MBLY) from Neutral ...

Four of 30 analysts are now bearish on the self-driving-technology stock, and the latest one sees about 20% further downside.

ISX038 will offer compatibility with the EyeQ™6 System-on-a-Chip (SoC) currently offered by Mobileye, for use in ADAS and AD ...

The bank reduced its rating on MobilEye to “underweight” from “neutral,” and cut the price target from $16 to $10, below Friday's close just under $13. Mobileye stock was down more than 4% Monday and ...

Mobileye shares slipped 5% during early Monday market action as it was downgraded to Underweight by J.P. Morgan. Read more ...

J.P. Morgan analyst Samik Chatterjee downgraded Mobileye stock to Sell from Hold. It’s the third Wall Street downgrade of the ...

Companies in the Consumer Cyclical sector have received a lot of coverage today as analysts weigh in on Rivian Automotive (RIVN – Research ...

The hype is huge, but Tesla is far from making a robotaxi you can bet your life on. So just what will they show to live up to the claim of "one for the history books?" ...

For investors looking for a blend of financial returns, “hasbarah” and cultural legacy, look no further than Israel.